CLINICAL_TRIALS ClinicalTrials.gov record update

Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03733249
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:33.869115+00:00
Published At: 2023-09-26T00:00:00+00:00
Record Updated At: 2023-09-26
Results Posted At: 2023-09-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Lymphoblastic Leukemia", "Leukemia, Acute Myeloid (AML), Child", "Lymphoma, Non-Hodgkin", "Myelodysplastic Syndromes", "Primary Immunodeficiency", "Anemia, Aplastic", "Hemoglobinopathies", "Cytopenia", "Fanconi Anemia", "Diamond Blackfan Anemia", "Thalassemia", "Anemia, Sickle Cell"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-09-26"
protocolSection.identificationModule.nctId: "NCT03733249"
protocolSection.identificationModule.officialTitle: "Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR \u03b1\u03b2+T Cells in Pediatric Patients Affected by Hematological Disorders"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-09-26"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.